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A7 phosphorylationMembrane fusion between the lamellar bodies and plasma membrane is an obligatory event in the secretion
of lung surfactant. Previous studies have postulated a role for annexin A7 (A7) in membrane fusion during
exocytosis in some cells including alveolar type II cells. However, the intracellular trafﬁcking of A7 during
such fusion is not described. In this study, we investigated association of endogenous A7 with lamellar bodies
in alveolar type II cells following treatment with several secretagogues of lung surfactant. Biochemical studies
with speciﬁc antibodies showed increased membrane-association of cell A7 in type II cells stimulated with
agents that increase secretion through different signaling mechanisms. Immuno-ﬂuorescence studies
showed increased co-localization of A7 with ABCA3, the lamellar body marker protein. Because these agents
increase surfactant secretion through activation of PKC and PKA, we also investigated the effects of PKC and
PKA inhibitors, bisindolylmaleimideI (BisI) and H89, respectively, on A7 partitioning. Western blot analysis
showed that these inhibitors prevented secretagogue-mediated A7 increase in the membrane fractions.
These inhibitors also blocked increased co-localization of A7 with ABCA3 in secretagogue-treated cells, as
revealed by immuno-ﬂuorescence studies. In vitro studies with recombinant A7 showed phosphorylation
with PKC and PKA. The cell A7 was also phosphorylated in cells treated with surfactant secretagogues.
Thus, our studies demonstrate that annexin A7 relocates to lamellar bodies in a phosphorylation-dependent
manner. We suggest that activation of protein kinase promotes phosphorylation and membrane-association
of A7 presumably to facilitate membrane fusion during lung surfactant secretion.11-050, Health Sciences Center,
; fax: +1 631 444 9142.
nder).
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Lung surfactant is essential for normal gas-exchange as it prevents
lung collapse at low volumes by lowering surface tension at air–liquid
interface during end-expiration. The principal surface-active compo-
nent, phosphatidylcholine, and other components of lung surfactant
are synthesized and secreted by lung epithelial type II cells by exocy-
tosis of stored surfactant in lamellar bodies. One of the obligatory
events during secretion is the membrane fusion between lamellar
bodies and plasma membrane in type II cells. Although several agents
promote lung surfactant secretion, and intracellular signaling mediat-
ing secretion has been extensively investigated [1–3], the mecha-
nisms that regulate such membrane fusion have been relatively
poorly investigated. We have previously shown that one of the
annexin proteins, annexin A7 (A7), can facilitate membrane fusion
between lamellar bodies and plasma membrane in vitro [4] and that
it can promote surfactant secretion in semi-permeable alveolar type
II cells [5]. More recently, our in vitro studies suggested that diacyl-
glycerol could regulate A7 function during membrane fusion, sincelamellar body enrichment with diacylglycerol increased the A7-
mediated membrane fusion activity [6].
In the scheme of A7-mediated membrane fusion during surfac-
tant secretion, we have postulated that binding of A7 to lamellar
bodies or plasma membrane would facilitate the membrane fu-
sion [7]. Several studies have suggested involvement of soluble N-
ethylmaleimide-sensitive fusion protein attachment receptor
(SNARE) proteins in membrane fusion during exocytosis (reviewed
in [8–11]). The assembly of SNARE protein complex is best charac-
terized in exocytosis at the synapse or intracellular cargo delivery
in the Golgi. The fusion complex formation involves members of
the vesicle (v)-SNARE (synaptic vesicle-associated membrane pro-
tein, VAMP) and target (t)-SNARE (members of syntaxin and snap
families) proteins. The pairing of cognate SNARE members allows
‘zippering’ to affect close apposition of the two fusing membranes
[12]. Although it is unclear if tight apposition between fusing mem-
branes is sufﬁcient to allow fusion, the presence of SNAREs in lipo-
some preparation is shown to achieve membrane fusion [13].
Nevertheless, a role for SNARE proteins in, at least, docking of secre-
tory vesicles on target membrane has been proposed in several
studies. In addition, other proteins have been invoked to facilitate
membrane fusion in type II cells. Lipid vesicle fusion is facilitated
by at least two of the annexin proteins, annexin A2 [14,15] and A7
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cells and have been suggested to play a role in lung surfactant secre-
tion [18]. Although it is proposed that annexin A2 and some of the
SNARE proteins can inﬂuence surfactant secretion, the regulation
of interactions between A2 and SNARE proteins has not been
investigated.
We and others have suggested that protein phosphorylation may
be one mechanism for membrane-association of annexin A7 [17,19].
In our previous studies, we have demonstrated preferential binding
of puriﬁed bovine A7 to isolated lamellar bodies and plasma mem-
brane fractions [19]. The in vitro binding to plasma membrane and la-
mellar body fractions from secretagogue-stimulated cells was higher
[19]. These studies also demonstrated that stimulation of cells in
presence of PKC inhibitor blocked the increased in vitro binding. In
chromafﬁn cells, phosphorylation of A7 with carbachol was increased
in the absence but not in the presence of PKC inhibitors [17]. Howev-
er, intracellular trafﬁcking of endogenous A7 and targets of A7 reloca-
tion has not been identiﬁed. In the current study, we determined the
‘in vivo’ partitioning of cell A7 between the membrane and cytosol
fractions. Immuno-staining with speciﬁc antibodies was employed
to determine A7 trafﬁcking to lamellar bodies, since these are in-
volved in surfactant secretion. Our studies demonstrate that all of
the established secretagogues for lung surfactant increase membrane
partitioning of cell A7 in type II cells. Some of this increase appears to
be due to partitioning into lamellar body membranes as determined
from co-localization of A7 with ABCA3, also known as P180, a lamellar
body speciﬁc protein [20,21]. Since protein kinase activation with
various secretagogues is important for stimulated secretion in type
II cells, we also investigated membrane-association of endogenous
A7 in presence of PKC and PKA inhibitors. Our studies support that in-
creased membrane-association of A7 in domains containing ABCA3,
i.e., lamellar bodies, is facilitated by protein kinase activation, which
could be permissive for membrane fusion during secretion.
2. Methods
2.1. Preparation of annexin A7 antibodies
Bacterially expressed puriﬁed recombinant A7 [22] was used to
raise antibodies in rabbits through a commercial source. The pooled
antiserum from two rabbits was cleaned by passing through rat
serum proteins coupled to CNBR-activated Sepharose 4B, before use
for studies reported here.
2.2. Isolation of alveolar type II cells
Lungs of male Sprague–Dawley rats (200–300 g, body weight)
were used for isolation of alveolar type II cells following protease di-
gestion as described previously [23]. The institutional animal care and
use committee had approved the handling and use of rats for studies
reported here. Brieﬂy, rats were anesthetized with Nembutal (50 mg/kg,
ip) and sacriﬁced by exsanguinations after severing major abdominal
blood vessels. The lungs were ventilatedwith a rodent respirator and vis-
ibly cleared by perfusion through pulmonary artery. Lungs were excised
following intra-tracheal instillation of porcine elastase (3 units/ml) and
incubated to partially digest the lung tissue. The lung lobes were minced
on a tissue-chopper, and the lung mince was mixed vigorously to release
free cells that show enrichment with alveolar type II cells. Themajor con-
taminating cells, themacrophages, were removed by adherence to bacte-
riological plates coated with rat serum IgG, which facilitates adherence of
macrophages through the Fc receptors. The free cells showing ~90% puri-
ty of type II cells (by acridine orange staining [24]) were suspended in
minimum essential medium (MEM) containing 10% fetal bovine serum
(FBS) and cultured for 20–22 h in tissue culture plastic dishes. The adher-
ent cells at the end of this culture period showed N95% purity of type IIcells and N97% routinely exclude vital dye Trypan Blue. The adherent
cells were used for all studies reported here.2.3. Cell treatment with agents
Following culture of type II cells for indicated periods, the cells
were washed repeatedly and equilibrated in fresh MEM for 30 min
before addition of secretagogues and incubated for speciﬁed periods.
Various agents were added from (100x) stock solutions. A stock solu-
tion of ATP (100 mM) was prepared in ice-cold water. In case of phor-
bol myristate acetate or A23187, the stock solutions were prepared in
ethanol and diluted 10-fold in MEM before addition so that the medi-
um contained 0.1% ethanol. Following incubations, the medium was
removed and the cells harvested by scarping in homogenization buff-
er (50 mM Tris-100 mM NaCl-0.5 mM EDTA-0.5 mM EGTA, pH 7.4)
containing protease and phosphatase inhibitors (1 mM PMSF and a
mixture of leupeptin, pepstatin and aprotinin, each 5 μg/ml, 1 mM
Na orthovanadate). The cells were disrupted by sonication on ice
(3×10 s) followed by passage through 27 1/2 G needle (x5) and the
membrane and the cytosol fractions were isolated by differential cen-
trifugation (100,000 g for 60 min) where applicable.2.4. Isolation of lung lamellar bodies
Rat lungs were cleared of residual blood by perfusion as described
above for isolation of alveolar type II cells. The visibly cleared lungswere
then given a bolus of 5 ml 1 M sucrose and the lung lobes harvested, dis-
sected free of airways and blotted on gauze pads. For isolation of lamel-
lar bodies by previously described methods [25], lung lobes were
disrupted with a Polytron® type tissue disruptor and homogenized in
1 M sucrose in Potter-Elvehjam type glass homogenizer. The lamellar
body enriched fraction from lung homogenatewas obtained by upwards
ﬂotation following centrifugation on a discontinuous gradient of 0.8 to
0.2 M sucrose. The lamellar body enriched fraction at the 0.5 and 0.4 M
sucrose interface was diluted to 0.2 M sucrose and the puriﬁed lamellar
bodies were isolated by differential centrifugation. We have previously
carried out extensive characterization of these isolated lamellar bodies
in terms of phospholipids composition, ultra-structure, and physiologi-
cal properties of maintenance of acidic pH and transport of other ions
[24–26].2.5. Immunoprecipitation of annexin A7
In some experiments, the adherent cells were harvested by scrap-
ing in ice-cold non-denaturing lysis buffer (50 mM Tris–HCl, pH 7.4,
0.3 M NaCl, 5 mM EDTA, 0.02% Na azide and 1% octyl β-D-glucoside)
to which 10 mM iodoacetamide, 1 mM PMSF, 1 μg/ml aprotinin and
2 μg/ml leupeptin were added before use. All processing was done
at or below 4° C unless indicated. The suspension was transferred to
pre-cooled centrifuged tubes, vortexed gently and lysed on ice for at
least 30 min. The suspension was cleared by centrifugation
(16,000 g×15 min) and used for immuno-precipitation with puriﬁed
antibodies to A7 bound to protein A-Sepharose beads. The beads were
pre-treated with preimmune serum before binding of antibodies.
Pilot studies were carried out to verify that preimmune serum did
not precipitate A7 from cell lysate. The antibody-bound beads
(10 μl) were incubated with bovine serum albumin (10 μl of 10%) to
block non-speciﬁc binding sites. The clariﬁed supernatant was
added and the beads incubated overnight with end-over-end mixing.
The beads were centrifuged (100 g for 150 s), washed (x4) with lysis
buffer and once with ice-cold phosphate-buffered saline. The proteins
bound to the beads were eluted and analyzed by immuno-blotting
using appropriate primary and HRP-conjugated secondary antibodies.
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Fig. 1. Surfactant secretagogues cause increased membrane-association of endogenous
annexin A7. A. Western blot demonstrates the speciﬁcity of antibodies to recombinant
rat annexin A7. Proteins (10 μg) in isolated lung lamellar bodies, lysates of isolated type
II cells cultured for 20–22 h, and 1 μg of recombinant rat annexin A7 (rA7) were probed
for annexin A7 using antibodies preincubated for overnight without (panel containing
lanes 4–6 and M) or with (panel with lanes 1–3 and M) 10 μg of recombinant rat
annexin A7 (rA7). Chemiluminescence was recorded by autoradiography on an X-ray
ﬁlm with both panels exposed simultaneously. The blot demonstrates the presence of
annexin A7 in lamellar bodies and isolated type II cells. Preincubation of antibodies
with excess antigen decreased the signal intensity in each lane. M — Molecular weight
markers with each position highlighted with a marker pen. B. Isolated rat alveolar type
II cells were incubated for 30 min without or with ATP (1 mM), A23187 (250 nM) or
PMA (80 nM). All of the recovered cytosol (c) and the membrane (M) fractions were
probed for annexin A7. The membranes were stripped and probed for actin. C. Densi-
tometry results of western blots for the membranes and cytosol fractions from several
experiments showing increased membrane-association of annexin A7 in cells treated
for 30 min with all three agents used, in comparison to the controls. For these experi-
ments, equal proportions of the cytosol and membrane fractions were probed for
annexin A7 levels by western blot analysis followed by densitometry analysis to deter-
mine relative distribution of annexin A7. Only membrane-associated A7 levels are
shown in each case for better clarity. Each secretagogue increased membrane-association
of annexin A7. Results are expressed as mean±SE of number of cell preparations shown
in parentheses. * Pb0.05— % distribution in control membranes was different in compar-
ison to all others.
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Equal proportions of isolated fractions from cells or immuno-
precipitated proteins were resolved on SDS-PAGE (4–20%), trans-
ferred to PVDF membranes, blocked with blocking solution contain-
ing 5% bovine serum albumin or fat-free dry milk, and reacted with
primary antibodies (1:1000 dilution unless indicated). The mem-
branes were then reacted with species-speciﬁc secondary antibodies
(1:10,000 dilution) and the antigen(s) detected by chemilumines-
cence using Super-Signal® reagent (Pierce). In experiments deter-
mining A7 distribution into the membrane and cytosol fractions,
equal proportions of both fractions were analyzed for the presence
of A7 by Western blot analysis. Blots were imaged by exposing to X-
ray ﬁlms or with a photo-imager (SynGene). Relative proportions of
protein in each fraction were determined by densitometry and
expressed as percent distribution.
2.7. Immuno-staining of cells
In studies designed to investigate A7 distribution by ﬂuorescence
imaging, type II cells were cultured for 20–22 h on glass cover slips.
The cover slips with adherent cells were washed and incubated
with agents as indicated, washed and ﬁxed in ice-cold methanol for
15 min at −20 °C. In some experiments, the cells were ﬁxed in 2%
paraformaldehyde and then permeabilized by a 10 min-treatment
with 0.1% Triton X-100. Both techniques yielded comparable results.
The cells were washed with PBS and stored at 4 °C in PBS until proces-
sing. For immuno-staining, the ﬁxed cells were blocked with donkey
serum and treated for 2 h with the primary antibodies (rabbit anti-
annexin A7 antibodies and monoclonal anti-ABCA3 from Covance,
1:500, each). The cells were washed and treated with FITC- or
Alexa568-labeled species-speciﬁc secondary antibodies (1:500,
each). The immuno-stained cells were viewed and imaged using a
laser confocal microscope.
2.8. Phosphorylation of recombinant annexin A7
Commercially available PKC and catalytic subunit of cAMP-
dependent protein kinase were employed to verify phosphorylation
of recombinant A7 according to previous published reports [17]. Brief-
ly, puriﬁed A7 (1 μg) was incubated in a total volume of 20 μl contain-
ing 20 μg PS and 120 ng PMA suspension in 0.1% Triton X-100, 1 mM
Ca2+, 10 ng rat brain PKC, speciﬁc activity 1.3 units/μg protein (Cal-
biochem) in 25 mM Tris buffer (pH 6.8). For phosphorylation with
PKA, the reaction was conducted in 20 μl total volume containing
1 μg A7 and 10 units of catalytic subunit of PKA (Promega) in 25 mM
Tris buffer (pH 6.8).The phosphorylation reaction was started with
the addition of 100 μM γ-ATP32 (sp activity, 2–5 mCi/mmole) plus
10 mMMgCl2. The reaction at 30 °C was terminated at indicated peri-
od by adding the loading buffer for SDS-PAGE. Proteins were separat-
ed by SDS-PAGE and stained with Coomassie Blue. The gels were air-
dried and radioactivity detected with a phosphorimager.
2.9. Other analyses
Proteins were quantiﬁed according to Bradford [27] using protein-
binding dye reagent (Bio-Rad) and bovine-γ-globulin as standard.
Results of western blot analysis were analyzed for statistical signiﬁ-
cance (Pb0.05) by ANOVA followed by Tukey's post-hoc test accord-
ing to the GraphPad software. Results of immuno-ﬂuorescence were
analyzed for co-localization using the Zeiss LSM 510, version2, soft-
ware with co-localization function (Zeiss Corporation). The ﬂuores-
cence intensities for different conditions were normalized to the
same pixel range for individual ﬂuorophore. Scatter plots were
obtained for the intensities of two probes and their co-localization
of the two probes was derived according to this program.3. Results
3.1. A7 antibody
Western blot analysis for A7 showed a single band at ~47 kDa in
24 h-cultured type II cells and in lamellar bodies isolated from rat
lung homogenate (Fig. 1A). The recombinant protein also migrated
2020 T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1813 (2011) 2017–2025with a similar molecular weight. The blot shows reactivity with 1 μg
of recombinant A7, but as low as 10 ng of A7 could be detected with
this antibody (at 1:3000, not shown). Antigen inhibition of antibody
reaction (lanes 1–3) was used to verify the speciﬁcity of antibody.
Overnight incubation of 10 μl of antibody with 10 μg of puriﬁed re-
combinant A7 strongly diminished reactivity with the recombinant
protein and with the A7 in type II cells or in lung lamellar bodies dem-
onstrating the speciﬁcity of antibody reaction.
3.2. Membrane-association of A7
The next series of studies were aimed to determine if stimulation
of type II cells with surfactant secretagogues increased membrane-Control
Anx A7 ABCA3
A23187
ATP
Isoprel 
PMA
Fig. 2. Immuno-staining shows increased co-localization of annexin A7 with ABCA3 in stimu
presence of 250 nM A23187, 1 mM ATP, 10 μM Isoproterenol or 80 nM PMA. Cells were then
are shown after adjusting for ﬂuorescence intensities to the same range. The DAPI-stained n
A7 and ABCA3 reactivity. All agents increased co-localization of annexin A7 with ABCA3. Repassociation of A7. In these studies, isolated type II cells were incubated
for 30 min without or with 80 nM PMA, 1 mM ATP or 250 nM A23187,
all established secretagogues for lung surfactant [2,3]. Western blots of
the cytosol and membrane fractions for the control and treated cells
showed that A7 was present in both fractions (Fig. 1B). Each agent
caused higher levels of A7 in the membrane fraction relative to the cy-
tosol fraction in comparison to the control, which showed that the
membrane-associated A7 levels were lower than in the cytosol. Since
all of the recovered cytosol andmembrane fractions from each cell sam-
ple were probed for A7, the requirement of conducting additional assay
for total protein in each fraction was not necessary for calculations of
relative distribution of A7 in the two fractions of each sample
(Fig. 1B). Nevertheless, we conﬁrmed that the distribution of actinMerge +DAPI
lated cells. Adherent type II cells were incubated for 30 min in the absence (Control) or
ﬁxed and stained for annexin A7 and ABCA3. Confocal ﬂuorescence microscopic images
uclei are shown only in the last panels to clearly show the ﬂuorescence due to annexin
resentative images are shown from experiments that were repeated at least two times.
EDC
A
Co
ntr
ol
PM
A
AT
P
A2
31
87
Iso
pro
ter
en
ol
0
20
40
60
80
100
-PK inhibitor
+PK inhibitor
*
** **
**
**
A
nn
ex
in
 A
7,
%
 in
 m
em
br
an
es
B
Fig. 3.Membrane-association of annexin A7 is inhibited by protein kinase inhibitors. Alveolar type II cells were incubated for 30min without or with protein kinase inhibitors, bisin-
dolylmaleimideI (BisI) or H-89 before treatment for 30 min without or with indicated secretagogues. Equal proportions of the membrane (M) and cytosol (c) fractions were probed
for the annexin A7 levels by western blot analysis. Western blot for fractions from cells treated with A23187 (A) shows increased membrane-association of A7, which was inhibited
in the presence of BisI. The distribution of actin was not affected by either A23187 or BisI. Similarly, PMA (B), ATP (C) and isoproterenol (D) increased membrane-association of A7,
which was inhibited by respective protein kinase inhibitor. E. Results of densitometry analysis of western blot images from all experiments. Results are relative distributions in the
membrane fraction as a percent of the total and are mean±SE of 3–12 cell preparations. * Pb0.05 in comparison to all other conditions in the absence of protein kinase (PK) in-
hibitor, ** Pb0.05 in comparison to respective condition in the absence of PK inhibitor (BisI or H-89, as appropriate).
2021T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1813 (2011) 2017–2025was unchanged by reprobing the membrane with actin antibodies.
The A7 distribution between the two fractions showed some variation
between different cell preparations. However, the percent distribution
in the membrane fraction was always higher in stimulated cells when
compared with the control cells (also see Fig. 3). The results of den-
sitometric analyses from several such experiments with the indicat-
ed secretagogues are shown in Fig. 1C. The total A7 levels in the
membrane and the cytosol fractions are 100% and the distribution
in the membrane fraction is expressed relative to the total. Even
with the above-described variability in A7 distribution between the
two fractions, our analysis showed that all secretagogues increased
the relative content of A7 in the membrane fraction, in comparison to
the controls. Similar results were observed with the β-adrenergic
agonist, isoproterenol (see below). Thus, increased A7 partitioning into
membranes in stimulated type II cells appears to be a common
response to cell treatment with agents that increase surfactant
secretion through the protein kinase C pathway (PMA and ATP),
increasing cell calcium (A23187) and through cAMP-dependent path-
way (isoproterenol or terbutaline).3.3. Membrane-partitioning of A7 by immuno-staining
The membrane-association of A7 in secretagogue-treated type II
cells was also investigated by immuno-staining. For these studies,
type II cells were allowed to adhere to glass cover slips during the
20–22 h cell culture. The adherent cells were washed and treated
for indicated periods with each secretagogue, ﬁxed in ice-cold meth-
anol and stained for the described proteins using appropriate anti-
bodies. Immuno-staining for A7 revealed its presence in the
cytoplasmic, nuclear and membrane compartments. Nuclear localiza-
tion of A7 has been previously reported in astroglial cells by immu-
nostaining and in astrocyte derived C6 rat glioblastoma cells by
localization of green ﬂuorescence protein (GFP)-A7 [28]. As observed
in our study, this report also demonstrated that calcium ionophore
A23187 increased membrane association of GFP-A7. Because
immuno-staining for A7 alone did not reveal continuous portioning
along the cell periphery in treated cells, we employed the co-
localization strategy to determine if A7 is localized to lamellar bodies,
which can be identiﬁed by the marker protein ABCA3. In control cells,
PMA
A23187
ATP
Control+BisI
ATP+BisI
Isoprel+H89 Isoprel 
A23187+BisI
PMA+BisI
Anx A7 ABCA3
Merge 
Control
Fig. 4. Protein kinase inhibitors diminish co-localization of annexin A7 and ABCA3 in secretagogue-stimulated cells. Isolated rat type II cells were pre-incubated for 30 min without
or with PKC inhibitor, BisI (for ATP, A23187 or PMA), or PKA inhibitor, H89 (for isoproterenol), before incubation for 30 min without or with indicated secretagogue. Confocal mi-
croscope ﬂuorescence images are shown for each agent. The adjacent image for each condition shows co-localization pattern as determined using the Zeiss LSM co-localization soft-
ware. The analysis showed that prior treatment with protein kinase inhibitor prevented the increase in co-localization of annexin A7 and ABCA3. Representative images from
several experiments are shown. Isoprel — isoproterenol.
2022 T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1813 (2011) 2017–2025annexin A7 staining was weak possibly because of its diffused distri-
bution throughout the cells (Fig. 2). Most cells expressed both A7 and
ABCA3, as determined from lower magniﬁcation images (not shown).
In initial studies, cell-stimulation with A23187 (250 nM) and PMA
(80 nM) showed a time-dependent increase in annexin A7 associa-
tion with the lamellar bodies, as indicated by its co-localization with
ABCA3 (not shown). In control cells, the co-localization coefﬁcients
for A7 and ABCA3 were 0.03 and 0.02, respectively. The coefﬁcients
increased as a function of time and were 0.25 and 0.54 with A23187
and 0.29 and 0.42 with PMA after 30 min stimulation. In subsequent
experiments, cells were stimulated for 30 min with 80 nM PMA,
250 nM A23187, 1 mM ATP or 10 μM isoproterenol. In each case,
annexin A7 co-localization with ABCA3 was greater (Fig. 2). Thus,our studies show that lamellar bodies were one of the target mem-
branes for annexin A7 in stimulated cells and that the increased
membrane-association of annexin A7 (Fig. 1B and C) was, in part,
due to association with the lamellar bodies.
3.4. Annexin A7 relocation is dependent upon protein kinase activation
Stimulus-dependent activation of PKC or PKA regulates lung sur-
factant secretion. In vitro studies showed that augmented binding of
puriﬁed bovine annexin A7 to the plasma membrane or lamellar
body fractions from type II cells stimulated with PMA or A23187
could be prevented by pretreatment of cells with PKC inhibitor cal-
phostin C [19]. In the current study, type II cells were pre-treated
Table 1
Co-localization coefﬁcients of annexin A7 and ABCA3 in alveolar type II cells in the ab-
sence or presence of protein kinase inhibitors.
Co-localization coefﬁcient
Without PK inhibitor With PK inhibitora
A7 with ABCA3 ABCA3 with A7 A7 with ABCA3 ABCA3 with A7
Control 0.05 0.06 0.12 0.14
ATP 0.17 0.32 0.01 0.00
PMA 0.33 0.63 0.01 0.00
A23187 0.21 0.54 0.03 0.00
Isoproterenol 0.25 0.67 0.09 0.15
Co-localization coefﬁcient (ratio of co-localizing pixels to the total number of pixels in
each channel) was determined from confocal image analysis using the Zeiss LSM 510
Software Co-localization (Function) program.
0: denotes the absence of co-localization.
a BisI or H89.
2023T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1813 (2011) 2017–2025for 30 min with bisindolylmaleimide I (BisI) and H-89, speciﬁc inhib-
itors of PKC and PKA, respectively, before treatment with indicated
secretagogues for lung surfactant. Western blot analysis of the cytosol
and membrane fractions from control and stimulated cells demon-
strated that A23187 increased membrane-association of cell A7
(Fig. 3A), which was blocked in cells pre-treated with BisI. As
shown in Fig. 1B, the distribution of actin was unchanged with
A23187 treatment with or without the presence of BisI. Similarly,
PMA (Fig. 3B), or ATP (Fig. 3C) stimulation caused relative increase
of endogenous annexin A7 in the membrane fraction, which was
also diminished by BisI pretreatment. Cell-stimulation with isoproter-
enol also increased membrane-association of A7, which was inhibited
in cells pre-treated with PKA inhibitor, H89 (Fig. 3D), but not with
BisI (not shown). Thus, phosphorylation through PKC or PKA activa-
tion caused A7 association with the membranes. Some variability in
percent distribution of A7 in the cytosol and membrane fractions, asA
C
Fig. 5. Annexin A7 phosphorylation in vitro and in vivo in alveolar type II cells. A. Phosphory
subunit of PKA and by puriﬁed rat brain PKC. Puriﬁed A7 (1 μg) was incubated with ATP-γ-3
stained to localize A7, and imaged with a phosphor-imager to determine phosphorylation. B
in the absence or presence of PKC. Puriﬁed A7 was incubated in the described assay mixtur
phosphorylation of A7 as determined by imaging of radioactivity using a phosphorimager. T
the 50 kDa maker. Right panel shows Coomassie Blue-stained gels showing comparable amo
ditions. C. Type II cells were incubated for indicated periods without or with 100 nM PMA an
with indicated antibodies showed a time-dependent increase in A7 phosphorylation at the s
indicated agents and harvested in lysis buffer. Equal amounts of cell lysate proteins were im
antibodies showed equal levels of A7 but increased reactivity with p-ser and p-thr antiboddiscussed under Fig. 1, can also be seen here. Nevertheless, increased
distribution in membrane fraction and the inhibition of such increase
in presence of protein kinase inhibitor were seen in every cell prepa-
ration. Densitometry analyses of western blots from several experi-
ments with all four secretagogues are summarized in Fig. 3E. Only
the percent of total cellular A7 (cytosol plus membrane fractions) in
the membrane fraction without or with the protein kinase inhibitor
(BisI or H-89) is shown in each case. These results indicate that all
of the secretagogues caused a common response of increased A7 asso-
ciation with the membranes in a protein kinase-dependent manner.
That protein kinase activation is required for A7 relocation to the
lamellar bodies was also demonstrated by immuno-staining studies.
As shown above, all of the indicated secretagogues increased the co-
localization of ABCA3 and annexin A7 (Fig. 4, left panels). The pattern
of co-localization for each condition is shown in the adjacent panel, as
derived by the program. The co-localization was, however, dimin-
ished if the cells were pre-treated with BisI (in case of ATP, A23187
or PMA) or with H89 (in case of isoproterenol) prior to the 30 min
treatment with indicated secretagogue (Fig. 4, right panels). Analysis
of confocal images shows that the co-localization coefﬁcients for both
proteins were higher in the absence than in the presence of protein
kinase inhibitor (Table 1). The coefﬁcients were higher for ABCA3 in
comparison to those for A7 suggesting that not all of the A7 was di-
rected to the lamellar bodies in stimulated cells. Thus, the immuno-
staining studies support the results of cell fractionation studies in
terms of protein kinase-dependent relocation of A7 to the
membranes.
3.5. Secretagogues cause annexin A7 phosphorylation
In vitro studies with recombinant A7 were conducted to deter-
mine phosphorylation with puriﬁed protein kinase enzymes, PKC
and cAMP-dependent protein kinase. The in vitro phosphorylation
for 60 min clearly showed that in addition to autophosphorylationB
D
lation of puriﬁed recombinant rat annexin A7 (rA7) by commercially available catalytic
2P in presence of required co-factors for 1 h. The proteins were separated by SDS-PAGE,
oth the kinase enzyme and rA7 were phosphorylated. B. Phosphorylation of puriﬁed A7
e in the absence or presence of PKC and in the presence of ATP-γ-32P. Left panel shows
he phosphorylation of PKC is indicated by double arrowhead. A7 position is just below
unts of A7 in two lanes. Results show no authophosphorylation of A7 under these con-
d the immuno-precipitates (IPs) were obtained with A7 antibodies. Western blots of IPs
erine and threonine residues. D. Type II cells were incubated for 30 min without or with
munoprecipitated using A7 antibodies. Western blots of IPs with A7, p-thr and p-ser
ies in stimulated cells in comparison to the controls.
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(Fig. 5A). As against autophosphorylation of PKC, A7 did not show
autophosphorylation when incubated in presence of 32P-ATP in the
absence of PKC (Fig. 5B). The phosphorylation was time-dependent
(not shown). Next, we evaluated in vivo phosphorylation of annexin
A7 without or with stimulation of type II cells with various secreta-
gogues. Initial studies evaluated the cell lysate by western blot analy-
sis using antibodies for phosphoamino acids from cells treated
without or with several secretagogues. All agents (A23187, PMA,
ATP and terbutaline) caused increased phosphorylation of several
proteins, as determined by reaction with these antibodies, including
those that migrated to the same position as annexin A7, as veriﬁed
by reprobing of blots with annexin A7 antibodies (not shown). There-
fore, next we determined the phosphorylation of A7 by immuno-
precipitation (Fig. 5C and D) with A7 antibodies. The A7 antibodies
speciﬁcally precipitated A7, since the non-immune serum did not
show immuno-precipitation of A7 (not shown). Subsequent western
blots analysis of immunoprecipitates from lysates of PMA-treated
cells showed increased phosphorylation of A7 at the serine and thre-
onine residues as analyzed with antibodies for phosphoserine (Santa
Cruz) and phosphothreonine (Sigma). The phosphorylation was in-
creased at 1 min and reached a maximum between 5 and 10 min
after cell stimulation (Fig. 5C). Increased phosphorylation of A7 was
also observed in cell treated for 10 min with ATP or A23187
(Fig. 5D). Thus, our studies indicate increased phosphorylation of A7
in secretagogue-stimulated type II cells.
4. Discussion
In this study, we provide new evidence suggesting a role for A7 in
the regulation of lung surfactant secretion. Our studies using cell frac-
tionation and immuno-colocalization with compartment-speciﬁc
markers demonstrate that established secretagogues of lung surfac-
tant increase association of endogenous A7 with the lamellar bodies,
a surfactant storage compartment which must fuse with plasma
membrane for the release of lung surfactant. Several studies have pre-
viously demonstrated the importance of protein kinase in the regula-
tion of lung surfactant secretion (reviewed in [1–3]. Along similar
lines, our studies show that protein kinase activation is important
for A7 relocation to speciﬁc membranes in stimulated cells, where it
possibly interacts with the lamellar body marker protein ABCA3. We
have previously suggested a role for annexin A7 in membrane fusion
during surfactant secretion since this protein increased surfactant se-
cretion in permeabilized type II cells [5]. Our present studies demon-
strating A7 co-localization with lamellar bodies further support a role
for A7 in membrane fusion during surfactant secretion.
Although all annexin proteins share the common property of
calcium-dependent binding to phospholipid membranes [29,30],
only annexin A2 and A7 have been demonstrated to facilitate mem-
brane fusion and have been postulated to play a role in membrane fu-
sion during exocytosis of lung surfactant. The ﬁndings that both
proteins relocate to membranes upon cell-stimulation with secreta-
gogues support their postulated role. However, it is not clear if pro-
tein kinase-dependent phosphorylation is important for relocation
of annexin A2 to the membranes, although annexin A2 knock-down
with siRNA was shown to lower stimulated secretion of lung surfac-
tant in type II cells. Our study shows that protein kinase activation
is important for relocation of A7 to the membranes including the la-
mellar bodies. Whereas our previous studies on in vitro membrane
binding of bovine A7 showed that PKC activation was required for in-
creased binding [19], our current study shows that ‘in vivo’ binding of
cell A7 required PKC or PKA activation in a stimulus-dependent man-
ner. Clearly, there is an overall similarity in membrane binding prop-
erties (protein kinase dependence) of puriﬁed and endogenous A7.
Previous studies have demonstrated in vitro phosphorylation of
recombinant annexin A7 and ‘in vivo’ phosphorylation of endogenousannexin A7 in isolated chromafﬁn cells [17]. The phosphorylation of
recombinant A7 was observed with several classes of commercially
available protein kinase enzymes, but only phosphorylation with
PKC increased its membrane aggregation property [17]. In compari-
son, phosphorylation of annexin A2 diminishes its membrane aggre-
gation properties [31]. Nevertheless, the endogenous proteins (A7
and A2) could behave differently from recombinant or puriﬁed pro-
teins because of cellular environment. Our studies, however, cannot
determine if the increase in membrane-association of annexin A7 in
stimulated cells occurs only due to phosphorylation of membrane
proteins, A7 or both. Future studies with phosphorylation defective
mutants could provide such answer.
Increased membrane-association of A7 in stimulated cells implies
the presence of speciﬁc docking domains in the target membranes
where speciﬁc proteins may interact with the phosphorylated A7.
These docking domains are present in the lamellar bodies as demon-
strated by protein kinase-dependent co-localization of A7 with
ABCA3. Although not investigated here, the plasma membrane is
reported to contain the t-SNARE proteins that may facilitate docking
of secretion vesicles prior to membrane fusion. Our in vitro studies
showed that surfactant secretagogues increase binding of puriﬁed bo-
vine A7 (non-phosphorylated) to type II cell plasma membranes, sug-
gesting that phosphorylation of membrane proteins facilitated
interaction with A7 [19]. Although PKC-dependent phosphorylation
of ABCA3 has not been reported, the ABC transporters contain a cyto-
plasmic nucleotide-binding domain and the regulatory domain of
ABCA1 has several putative phosphorylation sites [32,33]. Increased
phosphorylation of SNARE proteins, syntaxin [34] and snap [35] by
PKC has been associated with increased exocytosis and secretion in
other systems. In type II cells, the importance of syntaxin2 and
snap23 in surfactant secretion has been implicated [18], but their
phosphorylation with PKC or PKA activation remains to be deter-
mined. It is likely that phosphorylation of syntaxin and snap homo-
logues facilitates interaction with A7 and promotes membrane
fusion during surfactant secretion.
The lipid composition of membranes can regulate their interaction
with proteins. Our previous studies have demonstrated that molecu-
lar organization of A7 can be modiﬁed by membrane lipid composi-
tion and that PIP2, which is mostly present in the plasma
membrane, has a dramatic inﬂuence on annexin A7 properties [6].
Similarly, membrane insertion of synaptotagmin, which acts as a cal-
cium sensor in SNARE-mediated release of synaptic vesicles, is facili-
tated by PIP2 in the membranes [36]. Although this study did not
investigate A7 co-localization with PIP2, but A7 interaction with PIP2
and consequent changes in protein conformation [6] would suggest
that A7 possibly binds to PIP2-rich domains in the plasma membrane.
Previous studies have demonstrated activation of exocytic sites by
microdomains of PIP2 and syntaxin [37]. In case of A7 also, phospho-
lipase C-mediated hydrolysis of PIP2 could increase diacylglycerol
content in the membranes that may facilitate the membrane-fusion
function of A7 [6].
Others have postulated that A7 can function as a Ca2+ channel
[38] and act as Ca2+-dependent GTPase [39,40]. A7 phosphorylation
with PKC can be increased in presence of GTP leading to increased
membrane aggregation activity of A7 [39]. Thus, A7 can function as
a Ca2+ and GTP sensor. Annexin A7 together with PKC and GTP
could function like a G-protein during exocytosis [39]. Our prelimi-
nary studies show that A7 also relocates to t-SNARE containing com-
partments in stimulated type II cells (not shown). In this respect, A7
appears to function like synaptotagmin I during synaptic transmis-
sion where it may act as a Ca2+ sensor [41]. Our studies support A7
localization in domains enriched with t-SNARE proteins in stimulated
type II cells. Similar to A7, several SNARE-interacting proteins includ-
ing calmodulin [42], CaMKII [43], ENaC [44], synaptotagmins [45] and
synaptophysin [46] have been described (reviewed in [47]). While
most of these interact with either t- or v-SNARE proteins [45,48],
2025T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1813 (2011) 2017–2025synaptotagmin I has been reported to interact with both the t- and v-
SNARE proteins. Similarly, A7 interaction with t-SNARE proteins and
ABCA3, the secretory vesicle protein in type II cells, may facilitate
close juxtaposition of lamellar bodies and the exocytic sites to pro-
mote membrane fusion, in co-operation with SNARE proteins, during
surfactant secretion. This speculation is also supported by the pres-
ence of Ca2+ and phospholipids binding domains in A7 and in synap-
totagmins [41,49].
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